NYSE:CO

June 28, 2018 Open Letter from Jayhawk Capital to Sanpower Group regarding Global Cord Blood Corp

NEW YORK, June 28, 2018 /PRNewswire/ -- The following is an open letter sent June 28, 2018 from Jayhawk Capital, a significant minority shareholder of Global Cord Blood Corp (NYSE: CO), to Sanpower Group regarding Global Cord Blood Corp (NYSE: CO). Congratulations on finally completing the ...

2018-06-28 23:55 1270

Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2018

- Added 21,390 New Subscribers in 4Q18 - 4Q18 Revenues Amounted to RMB233.0 Million ($37.1 Million) - 4Q18 Operating Income Amounted to RMB42.2 Million ($6.7 Million) - 4Q18 Non-GAAP Operating Income Amounted to RMB102.9 Million ($16.4 Million) - Board Declared Dividend of $0.08 per ordinary share -...

2018-06-27 04:16 979

Global Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2018 Financial Results

Earnings Call Scheduled for 8:00 a.m. ET on June 27, 2018 HONG KONG, June 19, 2018 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company") today announced that it plans to release financial results for the fourth quarter and full year fiscal 2018 onTuesday, June 26, 2018, after ...

2018-06-19 20:00 933

China Cord Blood Corporation Announces Results of Extraordinary General Meeting of Shareholders to Change Company Name to "Global Cord Blood Corporation"

HONG KONG, March 16, 2018 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), a leading cord blood banking operator inChina, today announced the results of its extraordinary general meeting of shareholders, which was held onMarch 16, 2018, in Hong Kong S.A.R., China...

2018-03-16 20:30 1051

China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2018

* 3Q18 Added 24,229 New Subscribers * 3Q18 Revenues Up 22.0% YOY to RMB245.0 Million ($37.7 Million )                               * 3Q18 Operating Income Reached RMB78.4 Million ($12.0 Million) * Conference Call to be Held on February 27, 2018 at 8:00 a.m. ET HONG KONG, Feb. 27, 2018 /PRN...

2018-02-27 05:16 1288

China Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2018 Financial Results

Earnings Call Scheduled for 8:00 a.m. ET on February 27, 2018 HONG KONG, Feb. 14, 2017 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) (the "Company") today announced that it plans to release financial results for the third quarter and first nine months fiscal year 2018 onMonday, February...

2018-02-14 21:00 646

China Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2018 Financial Results

Earnings Call Scheduled for 8:00 a.m. ET on February 27, 2018 HONG KONG, Feb. 14, 2017 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) (the "Company") today announced that it plans to release financial results for the third quarter and first nine months fiscal year 2018 onMonday, February...

2018-02-14 21:00 1034

China Cord Blood Corporation to Change Corporate Name to "Global Cord Blood Corporation"

HONG KONG, Feb. 7, 2018 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), leading cord blood banking operator inChina, today announced that the Board of Directors of the Company (the "Board") has approved seeking shareholder approval regarding the change of the Co...

2018-02-07 20:00 1101

Nanjing Ying Peng Becomes Major Shareholder of China Cord Blood Corporation

HONG KONG, Jan. 31, 2018 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"),  a leading cord blood bank operator in China, today announced that Nanjing Ying Peng Hui Kang Medical Industry Investment Partnership (limited partnership) ("Nanjing Ying Peng"), via its su...

2018-01-31 21:00 713

Nanjing Ying Peng Becomes Major Shareholder of China Cord Blood Corporation

HONG KONG, Jan. 31, 2018 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"),  a leading cord blood bank operator inChina, today announced that Nanjing Ying Peng Hui Kang Medical Industry Investment Partnership (limited partnership) ("Nanjing Ying Peng"), via its su...

2018-01-31 21:00 1256

China Cord Blood Corporation Announces Results of 2017 Annual General Meeting

HONG KONG, Dec. 7, 2017 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced the results of its 2017 Annual Gener...

2017-12-07 21:30 946

China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2018

HONG KONG, Nov. 21, 2017 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced its unaudited financial results for ...

2017-11-21 05:15 1176

China Cord Blood Corporation to Report Second Quarter and First Half Fiscal 2018 Financial Results

HONG KONG, Nov. 13, 2017 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) (the "Company") today announced that it plans to release financial results for the second quarter and first half fiscal year 2018 onMonday, November 20, 2017, after the market close.  The Company will host a confer...

2017-11-13 19:00 902

October 31, 2017 Open Letter from Jayhawk Capital to Sanpower Group regarding China Cord Blood Corp

NEW YORK, Oct. 31, 2017 /PRNewswire/ -- The following is an open letter sent October 31, 2017 from Jayhawk Capital to Sanpower Group regarding China Cord Blood Corp (NYSE: CO). As significant minority shareholders of China Cord Blood Corp (NYSE: CO), we want to congratulate Sanpower Group on the...

2017-10-31 23:44 883

China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 7, 2017

HONG KONG, Sept. 22, 2017 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company will hold its 201...

2017-09-22 18:45 2420

China Cord Blood Corporation Announces Adoption of 10b5-1 Sales Plan

HONG KONG, Aug. 28, 2017 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) (the "Company") today announced that Magnum Opus Second (PTC) Limited, an entity holding ordinary shares on behalf of certain directors and members of senior management, has adopted a 10b5-1 sales plan to sell up to ...

2017-08-28 18:00 2364

China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2018

* 1Q18 Added 22,523 New Subscribers * 1Q18 Revenues Up 29.6% YOY to RMB224.2 Million ($33.1 Million )                               * 1Q18 Operating Income Reached RMB83.0 Million ($12.2 Million) * Conference Call to be Held on August 24, 2017 at 8:00 a.m. ET HONG KONG, Aug. 24, 2017 /PRNew...

2017-08-24 04:16 1753

China Cord Blood Corporation to Report First Quarter Fiscal 2018 Financial Results

HONG KONG, Aug. 17, 2017 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) (the "Company") today announced that it plans to release its preliminary unaudited first quarter fiscal 2018 financial results onWednesday, August 23, 2017, after the market close.  The Company will host a conferen...

2017-08-17 18:40 2372

July 26, 2017 Open Letter to the Board of China Cord Blood Corp from Jayhawk Capital

NEW YORK, July 27, 2017 /PRNewswire/ -- The following is an open letter sent July 26, 2017 U.S. time to the Board of Directors of China Cord Blood Corp (NYSE: CO) from Jayhawk Capital. We recommend the Board repurchase 30 million shares as an effective use of the excess cash on the balance shee...

2017-07-27 01:14 2101

China Cord Blood Corporation Files Its Annual Report on Form 20-F

HONG KONG, July 26, 2017 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company filed its Annual R...

2017-07-26 04:30 4084
1234567 ... 10